Switzerland: Biosynth acquires UK-based peptide producer CRB

Biosynth, a supplier of critical raw materials to the life science industry, has acquired Cambridge Research Biochemicals (CRB), a UK-based independent producer of custom-made peptide and antibody tools, supplying researchers in the pharmaceutical, life science and academic sectors. “CRB has a long history in the peptide and antibody field,” said Dr Urs Spitz, CEO and…